Reuters logo
BRIEF-Assembly Biosciences announces successful completion of ABI-h0731 phase 1A trial
February 16, 2017 / 12:15 PM / 9 months ago

BRIEF-Assembly Biosciences announces successful completion of ABI-h0731 phase 1A trial

Feb 16 (Reuters) - Assembly Biosciences Inc

* Assembly Biosciences announces successful completion of ABI-H0731 phase 1A trial and upcoming conference presentations

* Assembly Biosciences Inc- Intends to report results of phase 1A study at a scientific conference during 2017 for ABI-H0731 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below